Diagnosis and management of adrenal insufficiency

Irina Bancos, Stefanie Hahner, Jeremy Tomlinson, Wiebke Arlt

Research output: Contribution to journalReview article

88 Citations (Scopus)

Abstract

Adrenal insufficiency continues to be a challenge for patients, their physicians, and researchers. During the past decade, long-term studies have shown increased mortality and morbidity and impaired quality of life in patients with adrenal insufficiency. These findings might, at least partially, be due to the failure of glucocorticoid replacement therapy to closely resemble physiological diurnal secretion of cortisol. The potential effect of newly developed glucocorticoid drugs is a focus of research, as are the mechanisms potentially underlying increased morbidity and mortality. Adrenal crisis remains a threat to lives, and awareness and preventative measures now receive increasing attention. Awareness should be raised in medical teams and patients about adrenal insufficiency and management of adrenal crisis to improve clinical outcome.

Original languageEnglish (US)
Pages (from-to)216-226
Number of pages11
JournalThe Lancet Diabetes and Endocrinology
Volume3
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Adrenal Insufficiency
Glucocorticoids
Morbidity
Mortality
Hydrocortisone
Quality of Life
Research Personnel
Physicians
Research
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology
  • Medicine(all)

Cite this

Diagnosis and management of adrenal insufficiency. / Bancos, Irina; Hahner, Stefanie; Tomlinson, Jeremy; Arlt, Wiebke.

In: The Lancet Diabetes and Endocrinology, Vol. 3, No. 3, 01.03.2015, p. 216-226.

Research output: Contribution to journalReview article

Bancos, Irina ; Hahner, Stefanie ; Tomlinson, Jeremy ; Arlt, Wiebke. / Diagnosis and management of adrenal insufficiency. In: The Lancet Diabetes and Endocrinology. 2015 ; Vol. 3, No. 3. pp. 216-226.
@article{ccac2147f6ad4002a19474a40564f494,
title = "Diagnosis and management of adrenal insufficiency",
abstract = "Adrenal insufficiency continues to be a challenge for patients, their physicians, and researchers. During the past decade, long-term studies have shown increased mortality and morbidity and impaired quality of life in patients with adrenal insufficiency. These findings might, at least partially, be due to the failure of glucocorticoid replacement therapy to closely resemble physiological diurnal secretion of cortisol. The potential effect of newly developed glucocorticoid drugs is a focus of research, as are the mechanisms potentially underlying increased morbidity and mortality. Adrenal crisis remains a threat to lives, and awareness and preventative measures now receive increasing attention. Awareness should be raised in medical teams and patients about adrenal insufficiency and management of adrenal crisis to improve clinical outcome.",
author = "Irina Bancos and Stefanie Hahner and Jeremy Tomlinson and Wiebke Arlt",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/S2213-8587(14)70142-1",
language = "English (US)",
volume = "3",
pages = "216--226",
journal = "The Lancet Diabetes and Endocrinology",
issn = "2213-8587",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Diagnosis and management of adrenal insufficiency

AU - Bancos, Irina

AU - Hahner, Stefanie

AU - Tomlinson, Jeremy

AU - Arlt, Wiebke

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Adrenal insufficiency continues to be a challenge for patients, their physicians, and researchers. During the past decade, long-term studies have shown increased mortality and morbidity and impaired quality of life in patients with adrenal insufficiency. These findings might, at least partially, be due to the failure of glucocorticoid replacement therapy to closely resemble physiological diurnal secretion of cortisol. The potential effect of newly developed glucocorticoid drugs is a focus of research, as are the mechanisms potentially underlying increased morbidity and mortality. Adrenal crisis remains a threat to lives, and awareness and preventative measures now receive increasing attention. Awareness should be raised in medical teams and patients about adrenal insufficiency and management of adrenal crisis to improve clinical outcome.

AB - Adrenal insufficiency continues to be a challenge for patients, their physicians, and researchers. During the past decade, long-term studies have shown increased mortality and morbidity and impaired quality of life in patients with adrenal insufficiency. These findings might, at least partially, be due to the failure of glucocorticoid replacement therapy to closely resemble physiological diurnal secretion of cortisol. The potential effect of newly developed glucocorticoid drugs is a focus of research, as are the mechanisms potentially underlying increased morbidity and mortality. Adrenal crisis remains a threat to lives, and awareness and preventative measures now receive increasing attention. Awareness should be raised in medical teams and patients about adrenal insufficiency and management of adrenal crisis to improve clinical outcome.

UR - http://www.scopus.com/inward/record.url?scp=84924053877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924053877&partnerID=8YFLogxK

U2 - 10.1016/S2213-8587(14)70142-1

DO - 10.1016/S2213-8587(14)70142-1

M3 - Review article

C2 - 25098712

AN - SCOPUS:84924053877

VL - 3

SP - 216

EP - 226

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

SN - 2213-8587

IS - 3

ER -